High-level expression of DKK-3 is associated with chemoresistance and tumor volume progression in HNSCC [56,58], pancreatic [57] and esophageal cancer [10], and with poorer outcomes in HNSCC and esophageal cancer patients [10,70]. The gene discussed is DKK3; the disease is head and neck squamous cell carcinoma.